Literature DB >> 27459115

Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3β and sFRP1 in human pancreatic carcinoma.

Hong-Wei Yang1, Guang-Hui Liu1, Yu-Qiong Liu1, Hong-Chao Zhao1, Zhen Yang1, Chun-Lin Zhao1, Xie-Fu Zhang1, Hua Ye2.   

Abstract

Increasing study reports that Wnt/β-catenin signaling pathway plays an essential role in numerous cancers growth, progression and metastasis. Aberrant miR-940 expression has been studied in gastric and breast cancer. However, the molecular mechanism of miR-940 enhancing proliferation and metastatic ability in human pancreatic carcinoma is far from to know. Real-time PCR was used to quantify miR-940 expression. Luciferase reporter assays here were performed to verify the activity of Wnt/β-catenin signaling pathway and targeting gene relationships, and immunofluorescence assay was applied to observe β-catenin expressed intensity. Bioinformatics analysis together with in vivo and vitro functional analysis indicated the potential targeting genes of miR-940. Specimens from 15 pairs of patients with human pancreatic carcinoma were involoved to confirm the relationship between miR-940 expression and the GSK3β/sFRP1 through real-time PCR and western blot assays. Bioinformatics combined with cell luciferase function researches determined the possible regulation of miR-940 on the 3'-UTR of the GSK3β and sFRP1 genes, resulting in the Wnt/β-catenin signaling activation. Further, miR-940 knockdown significantly recovered GSK3β and sFRP1 expression and relieved Wnt/β-catenin-mediated cell invasion, migration, metastasis and proliferation. The ectopic up-regulation of miR-940 significantly suppressed GSK3β/sFRP1 expression and promoted pancreatic carcinoma proliferation and invasion. Our study suggested mechanistic relationship between miR-940 and Wnt/β-catenin in the development and progression of pancreatic carcinoma through regulation of GSK3β and sFRP1.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  GSK3β; Pancreatic carcinoma; Proliferation; miR-940; sFRP1

Mesh:

Substances:

Year:  2016        PMID: 27459115     DOI: 10.1016/j.biopha.2016.06.057

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  15 in total

1.  Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses.

Authors:  Ilyas Sahin; Aditya Eturi; Andre De Souza; Sahithi Pamarthy; Fabio Tavora; Francis J Giles; Benedito A Carneiro
Journal:  Cancer Biol Ther       Date:  2019-04-12       Impact factor: 4.742

Review 2.  Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer.

Authors:  Li Ding; Daniel D Billadeau
Journal:  Expert Opin Ther Targets       Date:  2020-03-21       Impact factor: 6.902

3.  LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer.

Authors:  Huihua Cai; Jie Yao; Yong An; Xuemin Chen; Weibo Chen; Di Wu; Boyang Luo; Yong Yang; Yong Jiang; Donglin Sun; Xiaozhou He
Journal:  Oncotarget       Date:  2017-05-16

4.  Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs.

Authors:  Mohammed H Rashed; Pinar Kanlikilicer; Cristian Rodriguez-Aguayo; Martin Pichler; Recep Bayraktar; Emine Bayraktar; Cristina Ivan; Justyna Filant; Andreia Silva; Burcu Aslan; Merve Denizli; Rahul Mitra; Bulent Ozpolat; George A Calin; Anil K Sood; Mohamed F Abd-Ellah; Gouda K Helal; Gabriel Lopez Berestein
Journal:  Oncotarget       Date:  2017-03-21

5.  Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.

Authors:  Hao-Tang Wei; Er-Na Guo; Xi-Wen Liao; Li-Sheng Chen; Jia-Lei Wang; Min Ni; Chi Liang
Journal:  Oncol Rep       Date:  2018-07-30       Impact factor: 3.906

6.  miR-940 potentially promotes proliferation and metastasis of endometrial carcinoma through regulation of MRVI1.

Authors:  Zhan Zhou; Ya-Ping Xu; Li-Juan Wang; Yan Kong
Journal:  Biosci Rep       Date:  2019-06-10       Impact factor: 3.840

Review 7.  Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.

Authors:  Monish Ram Makena; Himavanth Gatla; Dattesh Verlekar; Sahithi Sukhavasi; Manoj K Pandey; Kartick C Pramanik
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

8.  Salivary MicroRNA for Diagnosis of Cancer and Systemic Diseases: A Systematic Review.

Authors:  Giacomo Setti; Margherita E Pezzi; Maria Vittoria Viani; Thelma A Pertinhez; Diana Cassi; Cristina Magnoni; Pierantonio Bellini; Antonino Musolino; Paolo Vescovi; Marco Meleti
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

9.  MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2.

Authors:  Dejian Zhao; Wenzheng Han; Xia Liu; Dawei Cui; Yu Chen
Journal:  Thorac Cancer       Date:  2017-05-17       Impact factor: 3.500

Review 10.  Role of Secreted Frizzled-Related Protein 1 in Early Mammary Gland Tumorigenesis and Its Regulation in Breast Microenvironment.

Authors:  Alisson Clemenceau; Caroline Diorio; Francine Durocher
Journal:  Cells       Date:  2020-01-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.